Christopher James Walker

This study identifies BRAF mutations in AML, showing poor outcomes and unique co-mutation patterns, suggesting potential targeted therapies.

This study identifies HIFN, a novel TrkB activator, which improves visual function and retinal neuron survival in a mouse model of ocular trauma.

The paper develops a genetic toolkit to study DRG neuron subtypes, revealing their molecular, morphological, and functional diversity in response to mechanical and thermal stimuli.

The paper identifies a three-gene expression signature that predicts response to selinexor in multiple myeloma and glioblastoma.